Tero Järvinen
Principal Investigator
Tampere University
I'm working on
a month ago
drug screening technology combining in vivo phage display, microdialysis and high throughput sequencing to identify macrocyclic peptides capable to both homing and tissue penetration for efficient site-specific drug delivery
I'm looking for
a month ago
partners or licensing deal for the disease-selective vascular homing peptides for drug develivery and for the robust drug screening technology
About
Research focuses on molecular and biomedical approaches to enhance tissue regeneration, including multifunctional recombinant proteins for injured tissue repair and applications in regenerative medicine.
Special focus is on targeted delivery based on macrocyclic vascular homing peptides specific for vasculature at site of injury/disease.
Tero Järvinen
Principal Investigator
Tampere UniversityWork experience
Tampere University Hospital
Chief Surgeon
2012 - Present
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Results may appear later and can be imperfect.
Expertise
BiopharmaceuticsBiotechnologyCardiovascularDrug DeliveryMolecular BiologyMolecular Medicine
Last updated Sep 2026
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.